Celcuity   Report issue

For profit Phase 2 Phase 3
Founded: Hamel MN United States (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2019
NCT03812393
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Celcuity | Celcuity, Inc. | Celcuity, LLC